Pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolite in renal transplant recipients at steady state

Ming ZHANG,Zheng JIAO,Jian-yong ZHONG,Yun-qiu YU,Fu-ming LU
DOI: https://doi.org/10.3969/j.issn.1672-8467.2006.04.016
2006-01-01
Abstract:Purpose: To investigate the pharmacokinetics (PK) characteristics of total and free mycophenolic acid (MPA) and its glucuronide metabolite (MPAG) in renal transplant recipients at steady state. Methods: Plasma samples were collected from 12 renal transplant recipients administrated with MMF 0.75 g bid 7-10 days after transplantation. Total and free MPA and MPAG were determined by HPLC method. The unbound fraction of MPA and MPAG and their PK parameters were estimated. Results: The unbound fraction of MPA and MPAG were 96.50% ± 2% and 65.40% ± 8% respectively. The PK parameters for total and free MPA at steady state were tmax (1.92 ± 0.95) h, cmax (9.35 ± 3.35) mg/L and (0.54 ± 0.48) mg/L, AUC0-12 (20.24 ± 6.54) and (0.73 ± 0.52) mg·h· L -1, MRT0-12 (3.22 ± 0.90) h and (3.13 ± 0.99) h respectively. Those of MPAG were tmax (3.33 ± 1.72) h, cmax (97.33 ± 32.56) mg/L and (29.92 ± 8.46) mg/L, AUC0-12 (656.40 ± 148.20) and (222.10 ± 58.08) mg·h·L-1, MRT0-12(5.52 ± 0.42) h and (5.45 ± 0.46) h respectively. Conclusions: Inter-individual MPA PK characteristics were considerably variable and it may be better to monitor its free form concentration in clinical settings.
What problem does this paper attempt to address?